Summits preview scientific research in four areas

story3_arsFull-day Frontiers in Science Summits were a great success during Scientific Sessions 2016 based on feedback from those attending the sessions. The summits focused on Arrhythmia Research, Stem Cells, Thrombosis and Vascular Disease. Additionally, the Precision Medicine Summit was held during Scientific Sessions.

Sessions at the Precision Medicine Summit were presented by leaders in cardiovascular research and treatment, including AHA President Steven Houser, PhD, FAHA, and FDA Commissioner Robert Califf, MD, FAHA. They addressed diagnosis using genomic technology and personalizing cardiovascular surgery, and reviewed the FDA’s position on precision therapeutics for treating patients with cardiovascular disease.

“I think it’s very important that clinicians understand what’s happening with precision medicine because it is certainly going to impact our clinical practice and help patients,” said Kimberly Skelding, MD, FACC, FAHA, Geisinger Health System, Danville, Pennsylvania.

Mark Hamer, MD, Rochester Cardiopulmonary Group, Rochester, New York, was impressed with presentations at the Arrhythmia Research Summit.

“It was very good. The nice thing was it presented a lot of information in a short period of time,” Hamer said. “They really boiled it down to the essentials, the important points. They went in-depth on individual projects, and the question-and-answer session was very good. I feel like I’ve been brought up to date on a lot different topics in electrophysiology.”

The presentations on thrombosis, vascular disease and stem cells also attracted large audiences, said attendees, who added that they liked the format of the presentations.

“I think peripheral artery disease is a subject where much more research is needed, and that was the emphasis of this session,” said Ian Van Koeverden, UMC Utrecht, Utrecht, Netherlands. “So that was good. It was eye-opening.”